×
Quanterix EBIT 2016-2024 | QTRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Quanterix ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Quanterix EBIT 2016-2024 | QTRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Quanterix ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$221.8B
Boston Scientific (BSX)
$151.4B
Stryker (SYK)
$149.1B
EssilorLuxottica (ESLOY)
$125.1B
Medtronic (MDT)
$117.2B
Lonza Group Ag (LZAGY)
$46B
Haleon (HLN)
$43.1B
GE HealthCare Technologies (GEHC)
$40.1B
ResMed (RMD)
$37.1B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$25.6B
Zimmer Biomet Holdings (ZBH)
$22.1B
Insulet (PODD)
$19.4B
Baxter (BAX)
$16.7B
Smith & Nephew SNATS (SNN)
$11.1B
BellRing Brands (BRBR)
$10.1B
Sunny Optical Technology (SNPTF)
$10B
Bio-Rad Laboratories (BIO)
$10B
Demant (WILYY)
$8.7B
Lantheus Holdings (LNTH)
$6.4B
ICU Medical (ICUI)
$4.1B
Prestige Consumer Healthcare (PBH)
$3.9B
Envista Holdings (NVST)
$3.7B
Haemonetics (HAE)
$3.4B
Perrigo (PRGO)
$3.4B
GN Store Nord (GNNDY)
$3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B
Neogen (NEOG)
$2.5B
LeMaitre Vascular (LMAT)
$2.2B